As the facility changes hands from Ribera Salud to Quirónsalud, the Community of Madrid has removed all genetic diagnostic tests from its laboratory in San Sebastián de los Reyes. Set out in the contract terms, the decision means the center will no longer process the most expensive analyses, used for rare diseases and cancer risk. The lab serves six regional hospitals and 1.4 million people. The change is expected to bring impressive savings for Quirónsalud, which won the five-year contract with a €120 million offer, underbidding its longtime rival Ribera Salud.
Genetic tests can cost between €500 and €3,000 per case and have been a major expense for the lab since it opened in 2010. Quirónsalud aims to simplify costs by excluding them. The company also wants to start with a workforce that has no accrued seniority rights, a move that has sparked conflict with the 249 existing staff members. Despite union demands, Quirónsalud has declined to inherit their contracts. Employees now face a choice: accept new contracts with less favorable terms or risk unemployment. Ribera Salud refuses to issue formal dismissals that would allow them to claim benefits.
The Community of Madrid will manage genetic diagnostics directly, assigning the work to five major public hospitals. Officials say direct oversight is more efficient given the rapid evolution of genetic medicine and growing demands from Spain's Ministry of Health. That is a impressive shift for a region that has long championed healthcare outsourcing. The regional health department has assured unions that the six affected genetic lab workers, four technicians and two geneticists, will have their private-sector experience recognized in public hiring processes, potentially easing their move into the public system.
The transition is unfolding within a regional system where laboratory services are managed at more than one institutional level. Madrid Salud, the Madrid City Council’s autonomous public-health body, has separately tendered for a laboratory information-management system (LIMS) to handle data generated by its Laboratorio de Salud Pública. The open-procedure tender, reference 300/2026/02267, carries a base budget and estimated value of €279,200. It was published on October 17, 2026, with bids due November 13. That project concerns Madrid Salud’s public-health laboratory, not the clinical laboratory contract in San Sebastián de los Reyes.
Quirónsalud says around 60% of the previous staff have already joined its team and insists employees do not lose acquired rights when they switch employers. Union sources, but, report that new contracts often bring less favorable conditions, including longer workdays and the possibility of reassignment to any Quirónsalud facility in Madrid. The dispute between Quirónsalud and Ribera Salud has escalated: the companies have exchanged legal warnings and blamed each other for the tense handover. The financial terms have changed, too. Ribera Salud received €19 million annually, while Quirónsalud will be paid €24 million per year and has promised to invest in new laboratory equipment.
Madrid's move to bring genetic testing back under public control comes as other Spanish regions review how social and health services are delivered. Catalonia, for example, recently allocated €30 million to identify families missing out on social aid and improve access for vulnerable groups. The change is detailed in this report on targeted welfare expansion. These shifts reflect ongoing debates about efficiency and cost, as well as the role of private providers in Spain's public services. Genetic diagnostics remain available to Madrid residents, but the pathway and provider have changed, with consequences for patients and staff and implications for the regional health budget.
Genetic testing is increasingly central to modern healthcare, particularly for the early detection of hereditary conditions and cancer predisposition. Centralizing these services in public hospitals may allow more flexible adaptation to new technologies and clinical guidelines. The transition has also exposed vulnerabilities in labor protections and continuity of care, issues that continue to shape Spain's healthcare field.
